Overview

An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2017-09-25
Target enrollment:
Participant gender:
Summary
A study comparing the usability of the Autoinjector and Pre-filled Syringe of SB4 in Subjects with Rheumatoid Arthritis.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Bioepis Co., Ltd.
Treatments:
Etanercept